Related Experiment Videos
Summary of clinical experience with recombinant factor VIII products--Recombinate
1Department of Medicine, University of North Carolina, Chapel Hill 27599-7035.
Annals of Hematology
|January 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Immune tolerance induction: What have we learned over time?
Haemophilia : the official journal of the World Federation of Hemophilia·2018
Rap1b is critical for glycoprotein VI-mediated but not ADP receptor-mediated alpha2beta1 activation.
Journal of thrombosis and haemostasis : JTH·2009
Breeding in high-elevation habitat results in shift to slower life-history strategy within a single species.
The Journal of animal ecology·2008
Cellular immune responses in hemophilia: why do inhibitors develop in some, but not all hemophiliacs?
Journal of thrombosis and haemostasis : JTH·2005
B-domain deleted recombinant factor VIII preparations are bioequivalent to a monoclonal antibody purified plasma-derived factor VIII concentrate: a randomized, three-way crossover study.
Haemophilia : the official journal of the World Federation of Hemophilia·2005
Phase I study of a novel recombinant human soluble thrombomodulin, ART-123.
Journal of thrombosis and haemostasis : JTH·2004
Mesenchymal Stromal Cell Therapy in Cardiovascular Disease: Reconsidering Clinical Inconsistency Through the Mechanism-Endpoint Relationship.
Reviews in cardiovascular medicine·2026
Adjunctive Cryopreserved Amniotic Membrane for Recalcitrant Keratopathy: Long-Term Outcomes with Maintenance Therapy.
Clinical ophthalmology (Auckland, N.Z.)·2026
Early post-marketing safety profile of resmetirom in FAERS: an exploratory assessment of statin co-reporting.
Frontiers in pharmacology·2026
Recent advances in fucoidan for stem cell protection and regenerative tissue repair.
Carbohydrate polymers·2026